Corium, Inc.: Clinical Trials

9 trials sponsored by Corium, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 6 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 43Completed 3

Follow Corium, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening
Serdexmethylphenidate/dexmethylphenidate - Adult Attention Deficit Hyperactivity Disorder
Phase 4CompletedNYU Langone Health292023-11-132025-07-29
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH) - Attention Deficit/Hyperactivity Disorder
Phase 4CompletedCorium, Inc.1232023-06-022026-05-08
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo - Attention Deficit/Hyperactivity Disorder
Phase 4CompletedCorium, Inc.2462023-03-222025-05-13
Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
Donepezil TDS, Aricept - Healthy Subjects
Phase 1CompletedCorium, Inc.602020-12-082024-09-19
A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)
Donepezil TDS - Alzheimer's Disease
Phase 1CompletedCorium, Inc.242018-02-132018-09-14
A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations
Donepezil TDS - Alzheimer's Disease
Phase 1CompletedCorium, Inc.662018-01-312018-08-07
A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
Donepezil TDS, Vehicle TDS - Skin Irritation, Sensitization
Phase 1CompletedCorium, Inc.2562017-11-142018-09-14
A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
Donepezil TDS, Aricept - Alzheimer's Disease
Phase 1CompletedCorium, Inc.862017-10-302018-08-01
A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
Donepezil TDS Version A, Donepezil TDS Version B, Aricept - Alzheimer Disease
Phase 1CompletedCorium, Inc.1072016-11-012018-08-01

Conditions studied

Alzheimer Disease (4)  ·  Attention Deficit Disorder with Hyperactivity (3)

Interventions

Donepezil (3)  ·  Dexmethylphenidate Hydrochloride (2)  ·  serdexmethylphenidate and dexmethylphenidate (1)

Countries

United States (9)

Top investigators

Danielle Armas, MD (3)  ·  Ann Childress, MD (2)  ·  Danielle Armas (1)  ·  Danielle Armas, MD, CPI (1)  ·  Laura Sterling, MD, MPH (1)  ·  Lenard Adler (1)  ·  Robert Bass, MD (1)  ·  Vaeling Miller (1)

Results publications

PMID 36120781